How much funding has Freespira raised?

Freespira has raised $27.9M in total funding, most recently a Series E round.

Who are Freespira's investors?

Freespira's investors include Lightspeed VP, Aphelion Capital, Medvest Capital, Floodgate, First Round Capital, Baseline Ventures.

Where is Freespira headquartered?

Freespira is headquartered in Kirkland, Washington, United States.

What industry is Freespira in?

Freespira operates in Digital Health, Healthcare, Mental Health.

Freespira

Medication-free treatment for PTSD and panic disorder

Kirkland, United States · Founded 2013 · $27.9M raised

Digital Health

Healthcare

Mental Health

Headquarters: Kirkland, Washington
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: freespira.com
Total Funding: $27.9M
Last Round: $22.6M Series EApr 2024
Rounds: 5

About

Freespira, Inc. makes an at-home behavioral health treatment with FDA indications for PTSD and panic disorder symptoms. The clinically-validated solution combines a medical device (breathing sensor + tablet app) with high-touch support to deliver rapid and lasting symptom relief in just 28 days. The treatment is medication-free, targeting CO2 hypersensitivity linked to panic and PTSD. Health plans, employers, and providers use Freespira to improve quality of life and reduce unnecessary ER visits. 93% of subjects achieved a specified reduction in PTSD severity at two months post-treatment.

Summary

Freespira is a Digital Health company based in Kirkland, United States, founded in 2013. It has raised $27.9M in total across 5 rounds, most recently a $22.6M Series E round in Apr 2024. Investors include Lightspeed VP, Aphelion Capital and Medvest Capital.